CAS No. |
58-49-1 |
|---|---|
中文名称 |
(2S,5S,8S,11S,14S,17S)-2-[(1H-咪唑-5-基)甲基]-17-氨基-1-[(S)-2-[[(S)-1-羧基-2-苯基乙基]氨基甲酰基]吡咯烷-1-基]-14-[3-(二氨基亚甲基氨基)丙基]-8-(4-羟基苄基)-5,11-二异丙基-1,4,7,10,13,16-六氧代-3,6,9,12,15-五氮杂壬癸烷-19-酸 |
英文名称 |
(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-5,11-diisopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid |
别名 |
[VAL5]-ANGIOTENSIN II;[VAL5] ANGIOTENSIN II HUMAN;ASP-ARG-VAL-TYR-VAL-HIS-PRO-PHE;DRVYVHPF;5-L-Valine angiotensin II);Angiotensin II 5-valine (Valine angiotensin II;Valine angiotensin II;VALINE ANGIOTENSIN II;5-L-VALINE ANGIOTENSIN II |
标准英文名 |
(2S,5S,8S,11S,14S,17S)-2-((1H-imidazol-5-yl)methyl)-17-amino-1-((S)-2-(((S)-1-carboxy-2-phenylethyl)carbamoyl)pyrrolidin-1-yl)-14-(3-((diaminomethylene)amino)propyl)-8-(4-hydroxybenzyl)-5,11-diisopropyl-1,4,7,10,13,16-hexaoxo-3,6,9,12,15-pentaazanonadecan-19-oic acid |
分子式 |
C49H69N13O12 |
分子量 |
1032.17 |
精确分子量 |
1031.52 |
SMILES |
CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)C(C)C |
标准SMILES |
CC(C)[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(=O)N[C@@H](CC1C=CC(O)=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1C=CC=CC=1)C(O)=O |
用途 |
Angiotensin II 5-valine is an agonist of the angiotensin receptor and is used to study its role in hypertension and renal regulation; it induces significant increases in systolic blood pressure in rats and is utilized in research to investigate the effects of angiotensin receptor blockade (e.g., by losartan) on plasma and intrarenal angiotensin levels. |
InChIKey |
NLPUTBDZNNXHCO-CGHBYZBKSA-N |
|
|
评论 |
|---|